BioSpace News Archive

Nanoscope Therapeutics Inc., a late clinical-stage ocular gene therapy company, today announced the election of CEO Sulagna Bhattacharya to the Biotechnology Innovation Organization (BIO) Emerging Companies Section Governing Board.

Enanta Pharmaceuticals Announces Publication in The New England Journal of Medicine of Data from the Phase 2a Human Challenge Study of EDP-938 for the Treatment of Respiratory Syncytial Virus (RSV).

Unicompartmental knee replacement (UKR) is the most preferred surgical option for knee arthritis when only one compartment of the knee is involved.

The U.S. and EU-5 prefilled syringe small molecule market is prognosticated in a report by Transparency Market Research to find Sanofi, Mylan N.V., and Teva Pharmaceutical Industries Ltd. taking a leading position in terms of growth.

Pharmacovigilance is the profession of monitoring medical drug effects after being licensed.

Airway homeostasis is a crucial procedure controlled by nose. The infection or inflammation of sinuses resulting in the weakness of nasal lateral wall has significant effect on quality of patient’s life.

Fact.MR – A Market research and competitive intelligence provider: The global sales of animal vaccines are forecast to garner a market valuation of US$ 12 Bn in 2022 and is expected to register a positive market size at a CAGR of 9.2% by accumulating a market valuation of US$ 29 Bn through the assessment period 2022-2032

Verona Pharma plc announces that it will report its financial results for the fourth quarter and full year ended December 31, 2021 on Thursday, March 3, 2022 and host an investment community conference call at 9:00 a.m. EST / 2:00 p.m. GMT to discuss these financial results and provide a corporate update.

Ultimovacs ASA, a clinical stage leader in immune stimulatory vaccines for cancer, announces its fourth quarter 2021 results .

On Thursday February 24, at 09.00 CET, Devyser Diagnostics AB will host a conference call and an online presentation of its Q4 2021 interim report.